General Information of Drug (ID: DMBRYZ7)

Drug Name
RG6292
Synonyms CD25 mAb
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DK52QX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 2 receptor alpha (IL2RA) TT10Y9E IL2RA_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04158583) A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors.. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Roche.